Hypertension is emerging in many developing nations as a leading cause of cardiovascular mortality, morbidity and disability in adults. In sub-Saharan African (SSA) countries it has specificities such as occurring in young and active adults, resulting in severe complications dominated by heart failure and taking place in limited-resource settings in which an individual's access to treatment (affordability) is very limited. Within this context of restrained economic conditions, the greatest gains for SSA in controlling the hypertension epidemic lie in its prevention. Attempts should be made to detect hypertensive patients early before irreversible organ damage becomes apparent, and to provide them with the best possible and affordable nonpharmacological and pharmacological treatment. Therefore, efforts should be made for detection and early management at the community level. In this context, a standardized algorithm of management can help in the rational use of available resources. Although many international and regional guidelines have been published, they cannot apply to SSA settings because the economy of the countries and affordability of the patients do not allow access to advocated treatment. In addition, none of them suggest a clear algorithm of management for limitedresource settings at the community level. In line with available data and analysing existing guidelines, a practical algorithm for management of hypertension at the community level, including treatment affordability, has been suggested in the present work.
Introduction
According to the World Health Organization (WHO), hypertension is one of seven diseases composing the entity of 'cardiovascular diseases' (CVDs). 1 CVDs account for one-third of the worldwide global mortality and one-tenth of the worldwide global disease burden. 2 Low-and middle-income countries(LMICs) contribute to 80% of this global CVD burden, 2 where CVDs cause twice as many deaths as human immunodeficiency virus, malaria and tuberculosis combined, thus becoming the number one cause of death in the developing world. 3, 4 By its target organ damage, hypertension remains an important cause of coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease and heart failure. 5 The latter accounts for 470% of CVD's morbi-mortality worldwide, 1,3 making hypertension so far the major cardiovascular risk factor and a major component of the CVD entity.
In the LMICs of sub-Saharan Africa (SSA), the mortality among patients hospitalized for hypertension-related disorders is over 20%. 6 Hence, controlling major cardiovascular risk factors such as hypertension may reduce the CVD burden. 7 But in SSA, similar to other LMICs, one of the major constraints for controlling CVD in general and hypertension in particular is the limitation of resources for health care. 7 Primary prevention through a population-based lifestyle-linked programme, as well as cost-effective methods for detection and management, are synergistically linked. Cost-effective health-care interventions to reduce the cardiovascular burden can only be implemented if the health services policy environment and financing enable implementation. The control of hypertension supposes an early detection. In this context, there are currently no useful guidelines to detect and treat hypertension at community level in SSA.
The guidelines for management of hypertension change constantly as research findings shed more insight into the disease mechanisms and as new classes of antihypertensive agents are developed. As management of hypertension depends on a number of factors, including demographic and socio-economic realities, what is prescribed in developed countries may not be applicable in SSA. Up to now, many guidelines have been published but they are scarcely implemented in SSA as they do not suggest any practical management algorithm for health professionals in low-income countries. 8 In addition, restrained economic conditions in the developing world suggest that the greatest gains in controlling hypertension in SSA lie in its prevention and awareness of being hypertensive. Attempts should be made for early detection of hypertensive patients before irreversible organ damage becomes apparent, and providing them with the best possible and affordable non-pharmacological and pharmacological treatment.
This article analyses available data on hypertension complications in SSA and discusses the current hypertension management guidelines and ways to improve their implementation in SSA. The purpose is to interpret the available facts on the management of hypertension, to consider the realities of SSA and to suggest practical algorithms of hypertension detection and management at the community level in SSA low-and middle-income settings.
Materials and methods
A thorough literature search was performed on existing global and regional hypertension management guidelines. Country-based guidelines were skipped. In addition, an analysis was performed on published hospital data about prevalence of hypertension and its complications in SSA. In this review, 202 studies reporting hospital data from SSA were retrieved from the following databases: MED-LINE through PubMed, MBASE, African Index Medicus and WHO Global Cardiovascular InfoBase. Following search terms were used: sub-Saharan Africa/Africa, hypertension/high blood pressure, prevalence, hypertension complications, less developed countries/developing countries or nations, hospital/healthcare surveys, primary health care, African continental ancestry group, stroke, coronary (heart) diseases, heart failure, end-stage renal disease/renal failure and epidemiology. Additional searches were performed manually using references cited in reviews and original studies and no language exclusion was applied. To obtain data close to the current situation, only studies reporting data about prevalence and complications published between 1998 and 2008 were included. The reported prevalences were extracted as it is (in percentage), and overall results were expressed as medians. The retrieved articles included 167 papers using the current definition of hypertension. The reported prevalences (Table 1) were obtained in specialized cardiology centres (49 studies), internal medicine departments (21 studies) or in the entire hospital (97 studies).
Results and Discussion
Are international guidelines on management of hypertension applicable to SSA? Four main international or regional guidelines for the management of hypertension were analysed. 12 This guideline has been criticized for not considering cost effectiveness, or cost-savings issues, in the rational choice of antihypertensive drugs. 15 Moreover, this guideline is limited to the hospital setting and is not suitable for the community level. In addition, it is mainly based on blood pressure level threshold rather than the total cardiovascular risk and may yield a high number of people to treat, 16 whereas many SSA countries with limited resources cannot treat everyone with a blood pressure beyond the defined thresholds (blood pressure of X140/ 90 mm Hg). 9, 17 Because of a lack of clear risk stratification, it has been poorly implemented and health professionals in SSA tried rather to implement the international guidelines or to treat hypertension according to their daily experience. 18 This practice led to irrational use of available resources and a lack of harmonization in hypertension treatment in SSA region, which can have an effect on treatment optimization. 19, 20 Differences in hypertension risk between western countries and SSA countries Inhabitants of SSA have a higher risk to become hypertensive. Recognition of the special importance of hypertension in populations of African ancestry emerged in the United States in the 1930s. 21 By the 1960s, surveys had established a twofold greater prevalence of this disorder in blacks than in whites. 21 In contrast, the relatively low prevalence of hypertension in black people living in SSA may mistakenly suggest that the risk for hypertension is lower in SSA compared with western countries. Although the prevalence of hypertension was lower in SSA than in United Kingdom and United States, the prevalence of hypertension adjusted to the WHO standard population was higher in SSA than in United Kingdom and was similar in United States (Table 2 ). In addition, the analysis of age-specific prevalence data shows that the hypertension prevalence is higher at younger ages (up to 45 years) in SSA compared with western countries. The prevalence in old people is lower in SSA than in western countries. The plausible explanation is linked to low accessibility to treatment: by lacking adequate treatment people with hypertension died at younger age (approximately 45-54 years). People with hypertension at older age are likely new cases or survivors. The present data also show that country Management of hypertension in low-and middle-income countries M Twagirumukiza and LM Van Bortel prevalence data can be misleading as an indicator of the risk for becoming hypertensive.
Differences in risk from hypertension. The particular context of SSA containing poverty and illiteracy contributes to the low awareness, control and treatment rate of hypertension. 22 The limited resources devoted towards health care limit the number of health facilities added to the inexistence of health insurance scheme. 23 In such context, the cases of malignant hypertension and target organ damage are frequent. 24 As no official data on risk from hypertension or cardiovascular morbidity and mortality exist, data on risk from hypertension in SSA are mainly estimated from hospital data.
Data from in-hospital studies show that the most frequent complication reported downwards are heart failure, renal failure, stroke and CHD ( Table 1 ). The reported prevalences were obtained in specialized cardiology centres, internal medicine departments or in the whole hospital. Only few studies reported the mean age of the patient sample (15 out of 167 hospital studies), and this mean age ranged from 42.5±21.4 years to 53.8±17.0 years. The total range of age reported in hospital studies was 26-84 years.
Within 60 studies reporting cardiovascular accidents, only 17 studies reported CHD with a rather low prevalence. CHD is relatively uncommon in SSA, probably because blacks in SSA have lower serum cholesterol levels and higher high-density lipoprotein cholesterol levels. 12 Some researchers 25 merely link the CHD to mainly hypertension in SSA settings, and stress that CHD primary prevention should focus mainly on antihypertensive measures. Heart failure was most frequently reported (74 hospital studies) as a clinical consequence attributed to hypertension. Other potential causes of heart failure, such as rheumatic heart disease 24 or myocarditis (presumably linked to infectious diseases such as streptococcus and human immunodeficiency virus infections 26, 27 ), are frequent in SSA settings. However, the uncontrolled blood pressure remains the major factor for left ventricular hypertrophy 28 and heart failure. 29, 30 The same holds for stroke 24, 31, 32 and renal failure. [33] [34] [35] Despite insufficiency of statistical data about a relationship between hypertension and end-stage renal disease in SSA, current hospital data (Table 1) place end-stage renal disease in second position as a hypertension complication.
Similar to western countries, in SSA also stroke is a more common complication of hypertension and cause of death than myocardial infarction. 36 Stroke cases are presumed to occur at home and seldom reach the hospital. Therefore, it is likely that stroke is a more common complication than reported by hospital data. This is supported by investigations carried out in rural/urban areas; these reported data 32 show a high prevalence of stroke in black Africans in SSA, even higher than in western countries 31 and it is suggested that untreated hypertension is an important factor. 32, 37 The current findings, in line with other reports from developing countries, 38, 39 show that hypertension is emerging as a cardiovascular leading cause of mortality, morbidity and disability in adults in many developing nations. They also illustrate the economic consequences of hypertension in the LMICs of SSA. In this economic context, hypertension complications that occur at much earlier ages in SSA result in a greater number of years of potential life lost. Because of its high prevalence, the treatment of hypertension puts economic pressure on the SSA community.
Differences in total cardiovascular risk. The uncontrolled blood pressure is the main factor for target organ damage, and in SSA setting its proportion may be higher than in western countries. Other risk factors related to metabolic syndrome, diabetes and overweight, which were considered to be lower in some regions of SSA, will increase with urbanization and lifestyle change with modernization. 40 Despite the lower total cholesterol levels in SSA, the level of blood pressure may bring the total cardiovascular risk at the same magnitude as in western countries. In addition, hypertension bears the particularity of hitting the active young people, and then affecting the SSA economy. 41 Different focus in preventive strategies. The preventive actions concern habits and lifestyle monitoring. Two important low (or no)-cost preventive measures are: first, a reduction in dietary salt intake, 13 and second, a greater awareness of the implications of obesity. 42 There is good evidence that a reduction in salt intake reduces blood pressure and that black people are more sensitive than white people in this regard. 43 Other measures, such as increased physical exercise, 44 decreased obesity, cessation of smoking and limited alcohol consumption, 45 are all as important in black subjects as in whites in the prevention and control of hypertension. As hypertension is occurring at younger age in SSA than in western countries, regular check of blood pressure for all (also young) adult people should be promoted.
Diet control in SSA remains a great challenge. The diet is highly linked to the population culture, to the food conservation, cooking and other existing infrastructures. Salt reduction may be difficult in populations using it for food conservation. The implementation of controlled diets similar to what is promoted in Dietary Approaches to Stop Hypertension study 46 ,47 may be difficult in SSA settings because these measures require changes in preparation, conservation and other infrastructures and resources not available in SSA. As the conservation of food in SSA can be difficult, fresh food should be promoted.
Different focus in therapeutic strategies. Beyond prevention measures, [48] [49] [50] the management of hypertension also includes non-pharmacological 19, 51 and pharmacological treatment 52 and both bear specificities in SSA. Although the content of non-pharmacological treatment mainly based on lifestyle change and promoted by a patient education package remains similar in western countries and SSA, a difference in outcome can be expected from the high illiteracy rate in SSA. This may require different educational methods. Moreover, the population cultures and the real way of living (activities, historic habits such as salt intake, and so on) must be taken into account. Furthermore, as resources for managing hypertension are limited, it is important that interventions are guided by cost effectiveness for LMICs. 4 Hence, it is vital to use the scarce resources with maximum efficiency and guidelines should include drug affordability as main management component.
Hypertension management in public health perspective
Setting up a suitable guideline for the management of hypertension in SSA while taking into account the local situation remains the great challenge. 8 To our knowledge, this is the first paper to suggest an algorithm for early detection and management of hypertension at the community level in LMICs.
Beyond protocols suggested in the 2002 WHO Cardiovascular Risk Management Package in Lowand Medium-Resource Settings, 14 we propose a set of algorithms for detecting and managing hypertension in SSA at the community level (Figures 1-4) .
As the SSA region has its own disparities between countries, proposed algorithms offer the flexibility to be adapted to the countries' situation. As at the community level it is not feasible to have all parameters used in scoring total cardiovascular risk (such as total cholesterol), the proposed algorithm for the community level mainly relies on the blood pressure level, which is the main component in calculating the total cardiovascular risk. 53 In addition, the algorithm largely takes into account drug affordability. This algorithm is not suitable at the hospital level, in which other guidelines based on risk prediction charts 10,54 may apply. The proposed algorithm for community level is based on: (1) a twolevel management: at health advisor/worker and at the health centre; (2) detection and prevention of hypertension and non-pharmacological treatment at both levels, (3) prescription of a limited number (two) of low-dose affordable antihypertensive drugs limited to the health centre, (4) a management based on blood pressure level and presence of other cardiovascular risk factors and (5) referral of highrisk patients to the hospital.
Prerequisites are first to provide blood pressure devices at the community health advisor and health centre level and second to provide the core drugs (hydrochrolothiazide or other thiazides diuretics, and prazosin and/or reserpine) at the health centre level. The good storage of medicines at the health centre, the training of nurses and organization of population sensitization programs are also pre-requisite to implement the suggested algorithm. Implementation of the proposed algorithm may implicate new investment and a reorganization of the health sector in some places.
Measurements of blood pressure (BP)
in all adults (i.e. ≥ ≥25 years), at least once year.
If SBP≥ 140mmHg
and/or DBP ≥90mmHg and/or DBP ≥90mmHg Figure 1 Hypertension management strategy at the community level; at least, where a health advisor/worker is available. DBP ¼ diastolic blood pressure; NPT ¼ non-pharmacological treatment; SBP ¼ systolic blood pressure. *Symptoms to ask (yes means the person answers yes at least to one of following questions):-Shortness of breath on small exercise (such as climbing a small distance, walking, and so on)-Both feet swollen. **NPT includes:-Stop smoking (keep in mind all kind of tobacco use)-Overweight reduction and recommendation of a regular physical activity-Dietetic measures: (salt reduction, promote fresh fruits and vegetables intake, fatty food limitation, minimizing alcohol intake). As recommended by World Bank publication, 'Better Health for Africa', 55 at the community level (village) in a majority of SSA countries there are elected people called 'village health workers'. Even if these delegates have no formal medical training, they are generally the most educated of the population and they can be trained in taking just blood pressure at their offices in which they hold regular meetings with the population and give advice on non-pharmacological treatment and hypertension prevention.
Management of hypertension in low-
Health centres have nurses and other health professionals, but rarely a medical doctor. 56 The use of pre-established flowcharts for the management of hypertension at the community level is likely to increase patients' accessibility to health care. Sticks for detection of proteinuria and urine glucose are frequently available. If an electrocardiogram can be performed, the nurse must be trained to make a proper electrocardiogram recording, and to calculate the Cornell product for left ventricular hypertrophy detection. 57 Because of its high Figure 2) . HCTZ ¼ hydrochlorothiazide. The patient's treatment adherence is evaluated by patient and nearneighbourhood interviews. The goals to be achieved are stipulated in Figure 2 .
Management of hypertension in low-and middle-income countries M Twagirumukiza and LM Van Bortel specificity and better sensitivity, the Cornell product is preferred over other indexes such as SokolowLyon voltage 58 and the 12-lead QRS product. 57 Low-dose thiazide diuretics, proposed in the present algorithm, are still proposed as the backbone of hypertension treatment in general [59] [60] [61] [62] as they have a good affordability in most SSA countries. 63 In addition, at this low dose, dangerous side effects, such as hypokalaemia (which can induce arrhythmias), are less expected.
Although a-blockers such as prazosin may be an alternative to thiazides and also cheaper, they have the disadvantage of a three times daily intake, which can reduce treatment adherence. Other side effects of a-blockers, such as the 'first-dose effect' (inducing orthostatic hypotension), can be limited by starting the treatment with a low dose and increasing the dose slowly. For these reasons, a-blockers may not be first-line drugs at the health centre level. Reserpine or rauwolfia extracts offer the advantage of low cost and a once-daily administration. Side effects such as nasal congestion or depression are less frequent, provided the dosage of reserpine does not exceed 0.1 mg once daily. These drugs are proposed in third line at the health centre setting. They could be chosen in second line when compliance with prazosin is bad or when side effects occur.
Conclusions
Hypertension is emerging as a cardiovascular leading cause of mortality, morbidity and disability in adults in many developing nations. In contrast with western countries, there is a higher risk for hypertension in SSA and the higher risk is particularly found at the young age (o45 years). Hypertension complications in SSA are dominated by heart failure. To prevent complications, efforts should be made for early detection and management at the community level. International guidelines for hypertension management cannot apply to SSA settings, in which limited resources and patients' affordability do not allow access to advocated treatment. A practical algorithm for management of hypertension at the community level, including treatment affordability, has been proposed in the present work.
